| __timestamp | Viridian Therapeutics, Inc. | Walgreens Boots Alliance, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 3243000 | 54823000000 |
| Thursday, January 1, 2015 | 2472000 | 76691000000 |
| Friday, January 1, 2016 | 2548000 | 87477000000 |
| Sunday, January 1, 2017 | 19623000 | 89052000000 |
| Monday, January 1, 2018 | 30421000 | 100745000000 |
| Tuesday, January 1, 2019 | 32793999 | 91915000000 |
| Wednesday, January 1, 2020 | 28304000 | 95905000000 |
| Friday, January 1, 2021 | 620000 | 104442000000 |
| Saturday, January 1, 2022 | 755000 | 104437000000 |
| Sunday, January 1, 2023 | 1322000 | 112009000000 |
| Monday, January 1, 2024 | 121134000000 |
Unleashing the power of data
In the ever-evolving landscape of the pharmaceutical and retail sectors, the cost of revenue is a critical metric that reflects a company's operational efficiency. Walgreens Boots Alliance, Inc., a giant in the retail pharmacy space, consistently reported a cost of revenue exceeding $100 billion annually from 2018 to 2023. This figure underscores its vast scale and the efficiency required to maintain such operations. In stark contrast, Viridian Therapeutics, Inc., a smaller player in the biotech field, showed a more volatile trend, with costs peaking at around $32 million in 2019 before dropping significantly in subsequent years. This disparity highlights the differing scales and challenges faced by companies in these sectors. Notably, Viridian's data for 2024 is missing, indicating potential changes or challenges ahead. As we look to the future, these trends offer valuable insights into the operational dynamics of these industries.
AstraZeneca PLC vs Viridian Therapeutics, Inc.: Efficiency in Cost of Revenue Explored
Comparing Cost of Revenue Efficiency: Zoetis Inc. vs Viridian Therapeutics, Inc.
Cost of Revenue: Key Insights for Walgreens Boots Alliance, Inc. and Cytokinetics, Incorporated
Cost Insights: Breaking Down Walgreens Boots Alliance, Inc. and Supernus Pharmaceuticals, Inc.'s Expenses
Cost of Revenue Trends: Walgreens Boots Alliance, Inc. vs Wave Life Sciences Ltd.
Cost of Revenue Comparison: Walgreens Boots Alliance, Inc. vs Taro Pharmaceutical Industries Ltd.
Cost of Revenue Comparison: Exelixis, Inc. vs Viridian Therapeutics, Inc.
Cost Insights: Breaking Down Halozyme Therapeutics, Inc. and Viridian Therapeutics, Inc.'s Expenses
Cost of Revenue: Key Insights for Amphastar Pharmaceuticals, Inc. and Viridian Therapeutics, Inc.
Cost Insights: Breaking Down Taro Pharmaceutical Industries Ltd. and Viridian Therapeutics, Inc.'s Expenses
Cost of Revenue Comparison: Dyne Therapeutics, Inc. vs Viridian Therapeutics, Inc.
Cost of Revenue Comparison: Viridian Therapeutics, Inc. vs MiMedx Group, Inc.